Internal R&D program

In 2015, Aptys has started discussions with Unither Pharmaceuticals to develop a new drug for the treatment of moderate to severe pain

In 2016, the two companies have signed a collaboration agreement

In 2017, the project received the financial support of BPI,  Région Auvergne-Rhone-Alpe and Europe.